跳至主要内容
临床试验/NCT07154212
NCT07154212已完成不适用

Managing the Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Treated With Corticosteroids

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 1,793 人开始时间: 2020年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,793
试验地点
1
主要终点
HBV reactivation

研究概览

简要总结

The aim of this observational cohort study was to evaluate adherence to hepatitis B virus (HBV) screening guidelines in a country characterized by low HBV prevalence and assess the potential reactivation and progression of HBV infection in anti-HBV core antigen antibodies (anti-HBc) positive patients receiving corticosteroids for coronavirus disease 2019 (COVID-19).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hospitalized adult patients with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) polymerase chain reaction (PCR) test
  • supplemental oxygen
  • treated with corticosteroids for COVID-19 pneumonia

排除标准

  • age under 18 years
  • hospitalized for medical conditions unrelated to COVID-19
  • received corticosteroid therapy for non-COVID-19 reasons

结局指标

主要结局

HBV reactivation

时间窗: at least 3 months post treatment with corticosteroids

number (%) of patients with HBV reactivation

number (%) of patients with HBV reactivation

时间窗: one year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验